BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11485842)

  • 1. Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study.
    Andrejevic Blant S; Grosjean P; Ballini JP; Wagnières G; van den Bergh H; Fontolliet C; Monnier P
    J Photochem Photobiol B; 2001 Aug; 61(1-2):1-9. PubMed ID: 11485842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
    Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G
    J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
    de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
    Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.
    Blant SA; Glanzmann TM; Ballini JP; Wagnières G; van den Bergh H; Monnier P
    Br J Cancer; 2002 Dec; 87(12):1470-8. PubMed ID: 12454779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
    Andrejevic-Blant S; Hadjur C; Ballini JP; Wagnières G; Fontolliet C; van den Bergh H; Monnier P
    Br J Cancer; 1997; 76(8):1021-8. PubMed ID: 9376261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
    Savary JF; Monnier P; Fontolliet C; Mizeret J; Wagnières G; Braichotte D; van den Bergh H
    Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
    Andrejevic Blant S; Ballini JP; van den Bergh H; Fontolliet C; Wagnières G; Monnier P
    Photochem Photobiol; 2000 Mar; 71(3):333-40. PubMed ID: 10732452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial photodynamic therapy with tetra(m-hydroxyphenyl)chlorin: tumor versus striated muscle damage.
    Andrejevic-Blant S; Woodtli A; Wagnieres G; Fontolliet C; van den Bergh H; Monnier P
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):403-12. PubMed ID: 9788423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
    Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin.
    Grosjean P; Savary JF; Mizeret J; Wagnieres G; Woodtli A; Theumann JF; Fontolliet C; Van den Bergh H; Monnier P
    J Clin Laser Med Surg; 1996 Oct; 14(5):281-7. PubMed ID: 9612194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths.
    Braichotte D; Savary JF; Glanzmann T; Westermann P; Folli S; Wagnieres G; Monnier P; Van den Bergh H
    Int J Cancer; 1995 Oct; 63(2):198-204. PubMed ID: 7591204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
    Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
    Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
    Peng W; Samplonius DF; de Visscher S; Roodenburg JL; Helfrich W; Witjes MJ
    Lasers Surg Med; 2014 Oct; 46(8):650-8. PubMed ID: 25174329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.
    Braichotte DR; Savary JF; Monnier P; van den Bergh HE
    Lasers Surg Med; 1996; 19(3):340-6. PubMed ID: 8923430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and bioactivity of tetra-pegylated meta-tetra(hydroxyphenyl)chlorin compared to native meta-tetra(hydroxyphenyl)chlorin in a rat liver tumor model.
    Rovers JP; Saarnak AE; de Jode M; Sterenborg HJ; Terpstra OT; Grahn MF
    Photochem Photobiol; 2000 Feb; 71(2):211-7. PubMed ID: 10687396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.
    Copper MP; Tan IB; Oppelaar H; Ruevekamp MC; Stewart FA
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):709-11. PubMed ID: 12874068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence and absorption assessment of a lipid mTHPC formulation following topical application in a non-melanotic skin tumor model.
    Johansson A; Svensson J; Bendsoe N; Svanberg K; Alexandratou E; Kyriazi M; Yova D; Gräfe S; Trebst T; Andersson-Engels S
    J Biomed Opt; 2007; 12(3):034026. PubMed ID: 17614734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of the fluorescence measurement of Foscan in the normal human oral cavity as an indicator of its content in early cancers of the esophagus and the bronchi.
    Zellweger M; Grosjean P; Monnier P; van den Bergh H; Wagnières G
    Photochem Photobiol; 1999 May; 69(5):605-10. PubMed ID: 10333768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.
    Lorenz KJ; Maier H
    Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1937-44. PubMed ID: 19290535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
    Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.